Showing 1741-1750 of 3134 results for "".
- Sientra Gives Back: Company Launches Several Breast Cancer Awareness Initiativeshttps://modernaesthetics.com/news/sientra-gives-back-company-launches-several-breast-cancer-awareness-initiatives/2473306/Sientra is launching several initiatives in honor of Breast Cancer Awareness Month. Sientra has partnered with actress and breast cancer survivor, Miranda McKeon; collaborated with the Brem Foundation to launch “Sientra Supports”; and continues to support Re
- Facial Plastic Surgeons Give Back: AAFPRS Members Plan September Mission to Ukrainehttps://modernaesthetics.com/news/facial-plastic-surgeons-give-back-aafprs-members-plan-september-mission-to-ukraine/2473284/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) FACE TO FACE program will soon travel to the Ukraine on a medical mission to assist those with facial injuries suffered because of the Russia/Ukraine conflict. The nine-d
- Jeune Aesthetics Shares Positive Clinical Phase 1 Data for Investigational Gene-based Treatment to Address the Underlying Biology of Aging Skinhttps://modernaesthetics.com/news/jeune-aesthetics-shares-positive-clinical-phase-1-data-for-investigational-gene-based-treatment-to-address-the-underlying-biology-of-aging-skin/2473210/Jeune Aesthetics, Inc., a wholly-owned subsidiary of Krystal Biotech, Inc. shared positive proof-of-concept efficacy data from Cohort 2 of its PEARL-1 study of KB301, Jeune Aesthetics’ lead candidate for the treatment of aesthetic skin conditions. “We are pleased to see
- CollPlant’s rhCollagen-based Photocurable Dermal Filler Shows Promise for Facial Lifting and Sculpting and Breast Augmentation/Reconstructionhttps://modernaesthetics.com/news/collplants-rhcollagen-based-photocurable-dermal-filler-shows-promise-for-facial-lifting-and-sculpting-and-breast-augmentationreconstruction/2473173/CollPlant's photocurable dermal filler may enhance cell proliferation and new tissue regeneration for facial lifting and sculpting plus breast augmentation and reconstruction , according to
- New Survey on Reopening after COVID-19: If You Wear Masks, They Will Come Backhttps://modernaesthetics.com/news/new-survey-on-reopening-after-covid-19-if-you-wear-masks-they-will-come-back/2472957/Fully 85 percent of people plan to return to aesthetic treatments within 12 months of COVID-19 restrictions being lifted, and 63 percent plan to return to practices within just three months of restrictions being lifted in their respective countries, according to a
- FDA Clears Bimini Health Tech’s Dermapose Access Office-Based Fat Harvesting Systemhttps://modernaesthetics.com/news/fda-clears-bimini-health-techs-dermapose-access-office-based-fat-harvesting-system/2472922/Bimini Health Tech’s received US Food and Drug Administration (FDA) 510(k) clearance for its Dermapose Access, a novel fat harvesting system. Designed for office use, the launch of the Dermapose Access system creates a new pr
- From Baby Botox to Daddy Do-Overs, the Aesthetic Society Predicts the Hottest Trends for 2020https://modernaesthetics.com/news/from-baby-botox-to-daddy-do-overs-the-aesthetic-society-predicts-the-hottest-trends-for-2020/2472873/The Aesthetic Society predicts that 2020 will usher in the return of the facelift and the rise of the daddy do-over, i.e the male counterpart to t
- AAFPRS Members Look Into Their Crystal Balls for the Year Aheadhttps://modernaesthetics.com/news/aafprs-members-look-into-their-crystal-balls-for-the-year-ahead/2471970/Facial plastic surgeons are taking out their crystal balls to share a glimpse of what we will see more, or less of, in the coming year in cosmetic surgery. Natural-looking results are here to stay. Gone, but not totally forgotten are the highly sculpted nose
- New for EBD-Based Acne Care: Sebacia Microparticles Clearedhttps://modernaesthetics.com/news/new-for-ebd-based-acne-care-sebacia-microparticles-cleared/2472033/Sebacia Microparticles are now FDA-cleared for use in the treatment of acne. The clearance comes on the heels of a pivotal study demonstrating the clinical safety and efficacy of the micoparticles. Sebacia, Inc. had submitted its 510(k) submission to the FDA in June 2018. Sebacia Mic
- Sciton Gives Back for Breast Cancer Awareness Monthhttps://modernaesthetics.com/news/sciton-gives-back-for-breast-cancer-awareness-month/2472194/Sciton, Inc.’s Women's Health Group division and the Young Survival Coalition (YSC) are partnering to raise awareness about women's vaginal health, in particular, those who are recovering from breast can